to main content Stroke | The Joint Commission

Stroke


The following are Stroke eCQMs used by The Joint Commission.

  • eSTK-2 Discharged on Antithrombotic Therapy
  • eSTK-3 Anticoagulation Therapy for Atrial Fibrillation/Flutter
  • eSTK-5 Antithrombotic Therapy by End of Hospital Day Two
  • eSTK-6 Discharged on Statin Medication

Specifications for these measures are available below:

eCQM specifications  Screen Reader Text

There are no Stroke chart abstracted measures applicable or available for Accreditation purposes.

There are no Stroke eCQMs applicable or available for Certification purposes.

These Stroke chart abstracted measures were developed in collaboration with the American Heart Association (AHA)/American Stroke Association (ASA)/Brain Attack Coalition (BAC). The measure development and maintenance process is guided by expertise and advice provided by the Stroke Measure Maintenance Technical Advisory Panel (TAP).

The following are Stroke chart abstracted measures used by The Joint Commission.

  • Acute Stroke Ready Inpatient (ASR-IP)
    • ASR-IP-1 Thrombolytic Therapy: Inpatient Admission
    • ASR-IP-2 Antithrombotic Therapy By End of Hospital Day 2
    • ASR-IP-3 Discharged on Antithrombotic Therapy
  • Acute Stroke Ready Outpatient (ASR-OP)
    • ASR-OP-1 Thrombolytic Therapy: Drip and Ship
  • Comprehensive Stroke (CSTK)
    • CSTK-01 National Institutes of Health Stroke Scale (NIHSS) Score Performed for Ischemic Stroke Patients
    • CSTK-02 Modified Rankin Score (mRS) at 90 Days
    • CSTK-03 Severity Measurement Performed for SAH and ICH Patients
    • CSTK-04 Procoagulant Reversal Agent Initiation for Intracerebral Hemorrhage (ICH)
    • CSTK-05 Hemorrhagic Transformation
    • CSTK-06 Nimodipine Treatment Administered
    • CSTK-08 Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade
    • CSTK-09 Arrival Time to Skin Puncture
    • CSTK-10 Modified Rankin Score (mRS) at 90 Days: Favorable Outcome
    • CSTK-11 Rate of Rapid Effective Reperfusion From Hospital Arrival
    • CSTK-12 Rate of Rapid Effective Reperfusion From Skin Puncture
  • Stroke (STK)
    • STK-1 Venous Thromboembolism (VTE) Prophylaxis
    • STK-2 Discharged on Antithrombotic Therapy
    • STK-3 Anticoagulation Therapy for Atrial Fibrillation/Flutter
    • STK-4 Thrombolytic Therapy
    • STK-5 Antithrombotic Therapy By End of Hospital Day Two
    • STK-6 Discharged on Statin Medication
    • STK-8 Stroke Education
    • STK-10 Assessed for Rehabilitation
  • Stroke Outpatient (STK-OP)
    • STK-OP-1 Door to Transfer to Another Hospital
  • Stroke Volume (STK-VOL)
    • STK-VOL-1 Ischemic Stroke Patients Who Receive Mechanical Endovascular Reperfusion Therapy

    Specifications for these measures are available below:

    Chart-abstracted measures specifications  Screen Reader Text

Click on the link(s) below to access measure specific resources: